97 Results for "

CSF1 Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (97)

97 Results for "CSF1 Inhibitors" in MCE Product Catalog:

Cat. No.: HY-P99245
CAS No.: 1448221-67-7
Synonyms: RG 7155; RO 5509554

Target:  

c-Fms

Research Areas:  

Cancer

Emactuzumab(RG 7155) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour (dt-GCT) .
loading...
    loading...
Cat. No.: HY-124526
CAS No.: 1256349-48-0
Purity:  99.28%
Synonyms: Ibcasertib; CS2164
Research Areas:  

Cancer

Chiauranib (CS2164) is an orally active multi-target inhibitor against tumor angiogenesis. Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα and c-Kit), mitosis-related kinase Aurora B, and chronic inflammation-related kinase CSF-1R, with IC50 values ranging from 1-9 nM. Chiauranib has strongly anticancer effects .
loading...
    loading...
Cat. No.: HY-19772
CAS No.: 1018673-42-1
Synonyms: ESM-HDAC391; CHR-5154; HDAC-IN-3
Target:  

HDAC c-Fms

Research Areas:  

Inflammation/Immunology

GSK3117391 (ESM-HDAC391; CHR-5154; HDAC-IN-3) is an orally active HDAC inhibitor with a IC50 of 55 nM. Using esterase-sensitive motif technology, GSK3117391 is selectively converted into its active acid metabolite HDAC189 in cells expressing carboxylesterase-1. GSK3117391 induces sustained global protein acetylation in monocytes, inhibits the production of proinflammatory cytokines, depletes circulating monocytes, downregulates the expression of CSF1R, and inhibits monocyte adhesion and differentiation. GSK3117391 can be used in the research of chronic inflammatory diseases .
loading...
    loading...
Cat. No.: HY-145601
CAS No.: 2230490-29-4
Purity:  98.45%
Synonyms: TT 00420
Target:  

Aurora Kinase FGFR VEGFR

Research Areas:  

Cancer

Tinengotinib (TT00420) is an orally active, spectrally selective small molecule kinase inhibitor targeting Aurora A/B (IC50=1.2-3.3 nM), FGFR1/2/3 (IC50=1.5-3.5 nM), VEGFRs, JAK1/2 and CSF1R. Tinengotinib blocks Aurora kinase-mediated cell cycle progression (inducing G2/M arrest), inhibits FGFR/JNK-JUN signaling pathway and activates MEK/ERK-dependent apoptotic pathway. Tinengotinib has the activity of anti-tumor proliferation, inducing apoptosis, inhibiting angiogenesis and regulating tumor microenvironment. Tinengotinib can be used in the study of triple-negative breast cancer (TNBC), gallbladder cancer and tumor immune microenvironment .
loading...
    loading...
Cat. No.: HY-126297
CAS No.: 1527517-50-5
Purity:  98.63%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

c-Fms-IN-10 is the derivative of thieno [3,2-d] pyrimidine, an kinase inhibitor of FMS (Colony stimulating factor-1 receptor, CSF-1R) with IC50 of 2 nM. c-Fms-IN-10 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-159838
CAS No.: 2222689-47-4
Synonyms: EI‐1071
Target:  

c-Fms Amyloid-β

Research Areas:  

Neurological Disease Cancer

Enrupatinib (EI‐1071) is a potent, orally active, CNS-penetrant and selective CSF1R inhibitor. Enrupatinib inhibits macrophage proliferation and osteoclast differentiation in vitro. Enrupatinib preserves microglia distal to plaques. Enrupatinib mitigates Alzheimer's disease (AD)-related pathologies by reducing neuroinflammation, preserving neuronal integrity, lowering disease-associated microglia gene expression, and enhancing cognitive function in 5xFAD and J20 mouse models. Enrupatinib reduces tumor-associated macrophage infiltration and enhances antitumor activity of anti-PD-1 antibody in murine colorectal cancer and breast cancer models. Enrupatinib can be used for the research of AD, colorectal cancer, and breast cancer .
loading...
    loading...
Cat. No.: HY-112451
CAS No.: 959860-85-6
Purity:  99.88%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology

cFMS Receptor Inhibitor II is a CSF1R kinase inhibitor. CSF-1 is a cytokine .
loading...
    loading...
Cat. No.: HY-P991048
CAS No.: 2243120-07-0

Target:  

c-Fms

Research Areas:  

Cancer

AMG-820 is a fully human IgG2 antibody that targets CSF-1R. AMG-820 inhibits binding of the ligands CSF1 and IL34 and subsequent ligand-induced receptor activation. The isotype control for AMG-820 can refer to Human IgG2 kappa, Isotype Control (HY-P99002) .
loading...
    loading...
Cat. No.: HY-136362
CAS No.: 1313407-95-2
Purity:  99.63%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

ARRY-382 is a potent, oral and highly selective inhibitor of CSF1R/c-Fms with an IC50 of 9 nM. ARRY-382 can be used for the research of advanced or metastatic cancers .
loading...
    loading...
Cat. No.: HY-117273
CAS No.: 942507-42-8
Purity:  99.77%
Target:  

Raf Autophagy

Research Areas:  

Cancer

AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity .
loading...
    loading...
Cat. No.: HY-P990257

Target:  

c-Fms

Research Areas:  

Cancer

Anti-Mouse CSF1 Antibody (5A1) is a rat-derived anti-mouse CSF1 IgG1 κ type antibody inhibitor. Anti-Mouse CSF1 Antibody (5A1) can inhibit cells proliferation and macrophage-induced invasion. Anti-Mouse CSF1 Antibody (5A1) shows potent anti-tumor effect in various tumor models, such as neuroblastoma .
loading...
    loading...
Cat. No.: HY-147615
CAS No.: 2361556-35-4
Purity:  98.75%
Target:  

c-Fms

Research Areas:  

Cancer

CSF1R-IN-12 (compound 1) is a potent inhibitor of CSF1R. Colony stimulating factor 1 (CSF-1, also known as macrophage colony stimulating factor, M-CSF) is an important growth factor that controls bone marrow progenitor cells, monocytes, macrophages, and giants. CSF1R-IN-12 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-160842
CAS No.: 3024322-57-1
Target:  

c-Fms

Research Areas:  

Neurological Disease

CSF1R-IN-24 (Example 134) is an orally active CSF1R inhibitor. CSF1R-IN-24 significantly inhibits the survival of human ipSC-derived microglia (hiPSC-MG) .
loading...
    loading...
Cat. No.: HY-119942
CAS No.: 1255303-58-2
Purity:  99.47%
Target:  

c-Fms

Research Areas:  

Cancer

c-Fms-IN-8 (compound 4a) is a colony stimulating factor-1 receptor (CSF-1R, c-FMS) Type II inhibitor, with an IC50 of 9.1 nM .
loading...
    loading...
Cat. No.: HY-122906
CAS No.: 1255303-54-8
Purity:  99.95%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology

JTE-952 is a potent, oral active and selective Type II inhibitor of colony stimulating factor-1 receptor (CSF-1R or cFMS, type III receptor tyrosine kinase), with IC50 values of 13 nM and 261 nM for CSF1R and TrkA , respectively. Effective against a mouse collagen-induced model of arthritis .
loading...
    loading...
Cat. No.: HY-159108
CAS No.: 953798-95-3
Target:  

c-Fms

Research Areas:  

Cardiovascular Disease

AZ683 is a potent and selective 3-amido-4-anilinoquinoline CSF1R inhibitor. AZ683 has high affinity for CSF1R (Ki=8 nM; IC50=6 nM). AZ683 has good oral bioavailability. [ 11C]AZ683 can be used as a positron emission tomography (PET) radiotracer for colony stimulating factor 1 receptor (CSF1R) .
loading...
    loading...
Cat. No.: HY-132935
CAS No.: 2503015-75-4
Purity:  99.06%
Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

BPR1R024 is an orally active and selective colony-stimulating factor-1 receptor (CSF1R) inhibitor. BPR1R024 has potent CSF1R inhibition activity with an IC50 value of 0.53 nM. BPR1R024 can be used for the research of immuno-oncology .
loading...
    loading...
Cat. No.: HY-161025
CAS No.: 1807466-30-3
Target:  

c-Fms VEGFR

Research Areas:  

Cancer

SYHA1813 is a dual inhibitor of CSF1R and VEGFR. SYHA1813 has potent antitumor activity against GBM .
loading...
    loading...
Cat. No.: HY-13493
CAS No.: 1351522-04-7
Purity:  98.56%
Target:  

PDGFR c-Kit FLT3

Research Areas:  

Cancer

AC710 is a potent PDGFR inhibitor with Kds of 0.6, 1.57, 1, 1.3, 1.0 nM for FLT3, CSF1R, KIT, PDGFRα and PDGFRβ, respectively.
loading...
    loading...
Cat. No.: HY-145809
CAS No.: 1309805-49-9
Purity:  99.98%
FASN-IN-5 (example 11), a FASN inhibitor, can be used for the research of TH17- or CSF1 -mediated disease or disorder such as cancer, immunological disorders, and obesity .
loading...
    loading...